CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q2 2021 13F Portfolio Holders as of 6/30/2021

Type / Class
Equity / NAMEN AKT
Number of holders
486
Total Shares
40.5M
Shares change
-1.06M
Total reported value, excl. options
$6.56B
Value change
-$153M
Put/Call ratio
1.19
Number of buys
270
Number of sells
-170
Price
$161.89
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.